Form 4 Filing for Claire Babineaux-Fontenot

This filing reports a grant of 2,286 restricted stock units to Claire Babineaux-Fontenot, a director at Abbott Laboratories, on April 24, 2026. The award, granted under the 2026 Incentive Stock Program, will be settled in Abbott common shares on a one-to-one basis. Settlement occurs on the earliest of the director's separation from service, death, or a change in control. The shares were granted at no cost, with a post-transaction ownership of 7,603 shares. The filing also includes a power of attorney, dated June 13, 2025, appointing specific individuals to act on behalf of Claire Babineaux-Fontenot for SEC filings related to Rule 144 and Section 16(a) of the Securities Exchange Act of 1934. This authorization remains in effect until no longer required or revoked in writing.